{"nctId":"NCT03480009","briefTitle":"Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion","startDateStruct":{"date":"2018-07-28","type":"ACTUAL"},"conditions":["Abortion in First Trimester"],"count":156,"armGroups":[{"label":"Dextromethorphan, opted for narcotic prescription","type":"EXPERIMENTAL","interventionNames":["Drug: Dextromethorphan Hydrobromide","Drug: Oxycodone"]},{"label":"Placebo, opted for narcotic prescription","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Avicel PH101 (Microcrystalline Cellulose NF) for Compounding","Drug: Oxycodone"]},{"label":"Dextromethorphan, declined narcotic prescription","type":"EXPERIMENTAL","interventionNames":["Drug: Dextromethorphan Hydrobromide"]},{"label":"Placebo, declined narcotic prescription","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Avicel PH101 (Microcrystalline Cellulose NF) for Compounding"]}],"interventions":[{"name":"Dextromethorphan Hydrobromide","otherNames":["Robitussin, Delsym"]},{"name":"Avicel PH101 (Microcrystalline Cellulose NF) for Compounding","otherNames":["Avicel"]},{"name":"Oxycodone","otherNames":["Tylox, Percodan, OxyContin"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Women aged 18 and over\n* Willing to give voluntary consent\n* English-speaking\n* Eligible for medication abortion per Planned Parenthood of Western Pennsylvania protocol\n* Self-reported reliable cellular phone access for the duration of study participation\n* Able to receive and reply to a \"test\" text at time of consent\n* Willing to comply with the study protocol\n\nExclusion Criteria:\n\n* Use of selective serotonin reuptake inhibitors or monoamine oxidase inhibitors due to risk of Serotonin Syndrome\n* Allergy to any component of the medication abortion regimen or study drug\n* Has any other condition that, in the opinion of the investigator, would preclude informed consent, make study participation unsafe, complicate the interpretation of the study outcome data, or otherwise interfere with achieving the study objectives\n* Anticipated use of dextromethorphan during study period","healthyVolunteers":true,"sex":"FEMALE","genderBased":true,"genderDescription":"Must be pregnant to participate","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Worst Pain Measurement Via Numeric Rating Scale (NRS-11)","description":"Self-reported pain measurement via text-messaging system during first 24 hours after misoprostol administration. The scale is from 0 to 10, where 0 represents \"no pain\" and 10 represents \"the worst pain possible\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0","spread":null},{"groupId":"OG001","value":"7.0","spread":null},{"groupId":"OG002","value":"7.5","spread":null},{"groupId":"OG003","value":"6.5","spread":null}]}]}]},{"type":"PRIMARY","title":"Analgesic Usage During Medication Abortion","description":"Analgesic usage by study arm for women who received dextromethorphan vs. placebo as adjunct to routine pain management during medication abortion; missing data are for participants who did not take the specified pain medication.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"800","spread":null},{"groupId":"OG001","value":"600","spread":null},{"groupId":"OG002","value":"800","spread":null},{"groupId":"OG003","value":"1000","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1000","spread":null},{"groupId":"OG001","value":"1300","spread":null},{"groupId":"OG002","value":"800","spread":null},{"groupId":"OG003","value":"975","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"15","spread":null},{"groupId":"OG003","value":"15","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Pain Scores Via Numeric Rating Scale (NRS-11)","description":"Marginal mean pain scores via Numeric Rating Scale (NRS-11) over 24 hours. The scale is from 0 to 10, where 0 represents \"no pain\" and 10 represents \"the worst pain possible\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.93","spread":"2.92"},{"groupId":"OG001","value":"2.96","spread":"2.76"},{"groupId":"OG002","value":"2.70","spread":"2.95"},{"groupId":"OG003","value":"2.41","spread":"2.88"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Pain Control Satisfaction Via 4-pt Likert Scale","description":"Overall satisfaction with pain control, \"4\" being - \"Very good\" and \"1\" being \"Very bad\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"4","spread":null},{"groupId":"OG002","value":"5","spread":null},{"groupId":"OG003","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"30","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"8","spread":null}]},{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"5","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":62},"commonTop":["Nausea","Vomiting","Drowsiness","Diarrhea","Chills"]}}}